Al-Hallak MAG et al., 2025-05-09: Randomized trial in 60 patients with recurrent herpes labialis showing that methylene blue antimicrobial photodynamic therapy combined with photobiomodulation reduced pain more than acyclovir at several time points. A clinical synergy study for pain and healing in a viral skin lesion.
The aPDT + PBMT group outperforms the control group in reducing pain intensity at t1 (p = 0.011), t2 (p = 0.041), and t3 (p = 0.005). In addition, the aPDT + PBMT group outperformed the PBMT group at t3 (p = 0.020).
Al-Hallak MAG et al., 2025-05-09: Randomized trial in 60 patients with recurrent herpes labialis showing that methylene blue antimicrobial photodynamic therapy combined with photobiomodulation reduced pain more than acyclovir at several time points. A clinical synergy study for pain and healing in a viral skin lesion. Study type: three-arm randomized controlled trial. N=60. Country: Syria. MB 0.1%; diode laser 650 nm, 100 mW, 24 J/cm2 for aPDT; PBMT with the same laser; 120 s per spot. Funding: not stated. Conflicts: none. Comparator: 5% acyclovir plus inactive laser, and PBMT alone. Bearing SUPPORTS a combined aPDT + PBM effect on pain, not on "energy". Also filed as MTD-036, MTD-095 (claims C6, C7, F2). Study type: randomized trial.
